UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025200
Receipt number R000028993
Scientific Title The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.
Date of disclosure of the study information 2016/12/17
Last modified on 2021/12/13 08:26:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.

Acronym

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.

Scientific Title

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.

Scientific Title:Acronym

The investigation for the association between the choleretic effects of Inchinkoto and intestinal microenvironment in patients with obstructive jaundice.

Region

Japan


Condition

Condition

Patients with external biliary drainage due to obstructive jaundice.

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigate the efficacy and safety of Inchinkoto. Clarify the association between the efficacy of Inchinkoto and intestinal microflora, fecal organic acids, fecal pH, and serum levels of Inchinkoto components.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Choleretic effect of Inchinkoto;
Alterations of biliary concentrations of bile acid, total bilirubin, and direct bilirubin.
Alteration of total biliary flow.
2) Association between choleretic effect of Inchinkoto and intestinal microenvironment.
Investigate the association between the choleretic effect of Inchinkoto and intestinal microflora, fecal metabolome, fecal organic acids, and fecal pH.

Key secondary outcomes

Serum levels of total bilirubin and direct bilirubin.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TJ-135 TSUMURA Inchinkoto Extract Granules for Ethical Use. Oral administration of Hangeshashinto (7.5g/day t.i.d. before meals) for 3 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients with biliary stenosis.
2)Patients with biliary drainage by percutaneous transhepatic biliary drainage or endoscopic nasal biliary drainage. At least 3 days after biliary drainage.
3)Age over 20 years.
4)Inhospital patients.
5)Patients who can do oral intake.
6)Patients who agree to participate in this study.

Key exclusion criteria

1)Patients with severe complications such as renal, cardiac, hematologic, and metabolic diseases.
2)Patients who are taking "Kampo" within 4 weeks.
3)Patients who are taking choleretic drug within 4 weeks.
4)Patients in pregnant or who expect being pregnant.
5)Patients who are allergic to "Kampo".
6)Patients who are not eligible for this study by investigators' decision.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Nagino

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Surgery, Division of Surgical Oncology

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Aichi, Japan

TEL

0527442222

Email

yyoko@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Yukihiro
Middle name
Last name Yokoyama

Organization

Nagoya University

Division name

Department of Surgery, Division of Surgical Oncology

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Aichi, Japan

TEL

0527442218

Homepage URL


Email

yyoko@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Hospital

Institute

Department

Personal name



Funding Source

Organization

Tsumura & Co.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Institutional Review Board

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, Japan

Tel

0527442218

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

37

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 08 Day

Date of IRB

2017 Year 02 Month 21 Day

Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2021 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 09 Day

Last modified on

2021 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028993


Research Plan
Registered date File name
2016/12/17 ICKT new study 研究計画書 final 20161212修.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name